-
Epigenetic silencing and CRISPR-mediated reactivation of tight junction protein claudin10b (CLDN10B) in renal cancer
Villora, S. A., Zhao, Y., Silva, P. C., Hahn, A. A., Olanin, V., Groll, D., Maurer, S., Roetzer, V., Szymanski, W., Procida-Kowalski, T., Philipp, N., Koch, A., Bartkuhn, M., Graumann, J., Volckmann, R., Koster, J., Rossbach, O., Salzig, D., Dammann, R. & Sigges, C. & 3 others, , 1 Dec 2025, In: Clinical epigenetics. 17, 1, 102.Research output: Contribution to journal › Article › Academic › peer-review
-
Impact of treatment history on drug resistance of metastatic colorectal cancer organoids
Huismans, M. A., Smabers, L. P., Brunner, S. R., van Hoeck, A., Kaa, D. V. D., Franken, I. A., Wensink, E., Koster, J., Volckmann, R., Kranenburg, O., Koopman, M., Snippert, H. J. G. & Roodhart, J. M. L., 21 Nov 2025, In: iScience. 28, 11, 113801.Research output: Contribution to journal › Article › Academic › peer-review
-
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325, (S0959804922005172), (10.1016/j.ejca.2022.09.001)]
Langenberg, K. P. S., Meister, M. T., Bakhuizen, J. J., Boer, J. M., van Eijkelenburg, N. K. A., Hulleman, E., Ilan, U., Looze, E. J., Dierselhuis, M. P., Lugt, J. V. D., Breunis, W., Schild, L. G., Ober, K., van Hooff, S. R., Scheijde-Vermeulen, M. A., Hiemcke-Jiwa, L. S., Flucke, U. E., Kranendonk, M. E. G., Wesseling, P. & Sonneveld, E. & 34 others, , 15 May 2025, In: Eur. J. Cancer. 221, 115423.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications
